References
Friedheim E, Corvi C, Walker CH (1976) Meso-dimercaposuccinic acid: A chelating agent for the treatment of mercury and lead poisoning. J Pharm Pharmacol 28: 711–712
Friedheim E, Graziano JH, Popovac D, Dragovic D (1979) Treatment of lead poisoning by 2,3-Dimercapto-succinic acid. Lancet 2: 1234–1235
Goodman LS, Gilman A (1975) The pharmacological basis of therapeutics, 5th ed. Macmillan Comp., New York, pp 912–923
Gosselin RE, Hodge HC, Smith RP, Gleason MN (1976) Clinical toxicology of commercial products, 5th ed. Williams & Wilkins Co., Baltimore, pp 39–43
Graziano JH, Cuccia D, Friedheim E (1978) The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning. J Pharmacol Exp Ther 207: 1051–1058
Jenkins RB (1966) Inorganic arsenic and the nervous system. Brain 89: 479–498
Peterson RG, Rumack BH (1977) d-Penicillamin therapy of acute arsenic poisoning. J Pediatr 91: 661–666
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lenz, K., Hruby, K., Druml, W. et al. 2,3-Dimercaptosuccinic acid in human arsenic poisoning. Arch Toxicol 47, 241–243 (1981). https://doi.org/10.1007/BF00368684
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00368684